Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Paradiso

Showing results (81-90 of 191) with videos related to

Pageof 20
Sort By:
Molecular Cancer Therapeutics|August 8, 2006
Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancerAmalia Azzariti, Nicola A Colabufo, Francesco Berardi, et al.
International Journal of Molecular Sciences|August 28, 2020
DEAD-Box Helicase 4 (Ddx4)<sup>+</sup> Stem Cells Sustain Tumor Progression in Non-Serous Ovarian CancersStella D'Oronzo, Erica Silvestris, Domenica Lovero, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 24, 2007
Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometryAntonella Aresta, Cosima D Calvano, Francesco Palmisano, et al.
Biochemical and Biophysical Research Communications|March 14, 2002
Gelatinase levels in male and female breast cancerGianluigi Giannelli, Emilia Fransvea, Felice Marinosci, et al.
Breast Cancer Research : BCR|November 13, 2004
The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cellsAngelo Paradiso, Rosa Angela Cardone, Antonia Bellizzi, et al.
Journal of Translational Medicine|November 1, 2008
"Sequencing-grade" screening for BRCA1 variants by oligo-arraysAlessandro Monaco, Filippo Menolascina, Yingdong Zhao, et al.
Clinical Colorectal Cancer|December 17, 2002
Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevanceJian-Ming Xu, Amalia Azzariti, Stefania Tommasi, et al.
International Journal of Molecular Sciences|September 9, 2014
CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimenNicola Silvestris, Giovanni Simone, Giulia Partipilo, et al.
International Journal of Oncology|December 23, 2014
The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cellsAntonia Bellizzi, Maria Raffaella Greco, Rosa Rubino, et al.
Journal of Translational Medicine|November 20, 2014
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patientsKatia Danza, Simona De Summa, Brunella Pilato, et al.
Pageof 20

Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|August 8, 2006
Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancerAmalia Azzariti, Nicola A Colabufo, Francesco Berardi, et al.
International Journal of Molecular Sciences|August 28, 2020
DEAD-Box Helicase 4 (Ddx4)<sup>+</sup> Stem Cells Sustain Tumor Progression in Non-Serous Ovarian CancersStella D'Oronzo, Erica Silvestris, Domenica Lovero, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 24, 2007
Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometryAntonella Aresta, Cosima D Calvano, Francesco Palmisano, et al.
Biochemical and Biophysical Research Communications|March 14, 2002
Gelatinase levels in male and female breast cancerGianluigi Giannelli, Emilia Fransvea, Felice Marinosci, et al.
Breast Cancer Research : BCR|November 13, 2004
The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cellsAngelo Paradiso, Rosa Angela Cardone, Antonia Bellizzi, et al.
Journal of Translational Medicine|November 1, 2008
"Sequencing-grade" screening for BRCA1 variants by oligo-arraysAlessandro Monaco, Filippo Menolascina, Yingdong Zhao, et al.
Clinical Colorectal Cancer|December 17, 2002
Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevanceJian-Ming Xu, Amalia Azzariti, Stefania Tommasi, et al.
International Journal of Molecular Sciences|September 9, 2014
CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimenNicola Silvestris, Giovanni Simone, Giulia Partipilo, et al.
International Journal of Oncology|December 23, 2014
The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cellsAntonia Bellizzi, Maria Raffaella Greco, Rosa Rubino, et al.
Journal of Translational Medicine|November 20, 2014
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patientsKatia Danza, Simona De Summa, Brunella Pilato, et al.
Pageof 20